IL-33 promotes the induction of immunoglobulin production after inhalation of house dust mite extract in mice

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 5, 2015, Pages 522-532

  Canbaz, D ^a   Utsch, L ^a   Logiantara, A ^a   Van Ree, R ^a,b   Van Rijt, Leonie S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

dendritic cells; house dust mite; immunoglobulin; innate immunity; interleukin 33; lung

Indexed keywords

ENDOTOXIN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 33; RECOMBINANT CYTOKINE; ALLERGEN; CYTOKINE; IL33 PROTEIN, MOUSE; IMMUNOGLOBULIN G;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BONE MARROW DERIVED DENDRITIC CELL; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; EX VIVO STUDY; FEMALE; HISTOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INHALATION; MOUSE; MOUSE MODEL; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; ANIMAL; ASTHMA; BLOOD; DENDRITIC CELL; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE MODEL; HUMORAL IMMUNITY; HYPERSENSITIVITY; IMMUNOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ALLERGENS; ANIMALS; ASTHMA; CYTOKINES; DENDRITIC CELLS; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-33; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; TH2 CELLS;

EID: 84926407102     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12594     Document Type: Article

References (35)

1. Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B, et al. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study. J Allergy Clin Immunol 2004; 114: 1033-1039.
2. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN,. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15: 410-416.
3. Valerio CR, Murray P, Arlian LG, Slater JE,. Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol 2005; 116: 1296-1300.
4. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457: 585-588.
5. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht BN, et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012; 209: 1505-1517.
6. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA,. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106: 551-559.
7. Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132: 933-941.
8. Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau JE, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013; 131: 187-200.
9. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008; 20: 791-800.
10. Nakanishi W, Yamaguchi S, Matsuda A, Suzukawa M, Shibui A, Nambu A, et al. IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS ONE 2013; 8: e78099.
11. Besnard AG, Togbe D, Guillou N, Erard F, Quesniaux V, Ryffel B,. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 2011; 41: 1675-1686.
12. Ohno T, Morita H, Arae K, Matsumoto K, Nakae S,. Interleukin-33 in allergy. Allergy 2012; 67: 1203-1214.
13. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363: 1211-1221.
14. Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 2014; 134: 170-177.
15. Prefontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009; 183: 5094-5103.
16. Kearley J, Buckland KF, Mathie SA, Lloyd CM,. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009; 179: 772-781.
17. van Rijt LS, Prins JB, Leenen PJ, Thielemans K, de Vries VC, Hoogsteden HC, et al. Allergen-induced accumulation of airway dendritic cells is supported by an increase in CD31(hi)Ly-6C(neg) bone marrow precursors in a mouse model of asthma. Blood 2002; 100: 3663-3671.
18. van Rijt LS, Vos N, Willart M, Muskens F, Tak PP, van der Horst C, et al. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am J Respir Crit Care Med 2011; 184: 303-311.
19. van Rijt LS, Kuipers H, Vos N, Hijdra D, Hoogsteden HC, Lambrecht BN,. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J Immunol Methods 2004; 288: 111-121.
20. van Rijt LS, Logiantara A, Utsch L, Canbaz D, Boon L, van RR,. House dust mite allergic airway inflammation facilitates neosensitization to inhaled allergen in mice. Allergy 2012; 67: 1383-1391.
21. Silva JS, Andrade AC, Santana CC, Santos LQ, Oliveira CI, Veras PS, et al. Low CXCL13 expression, splenic lymphoid tissue atrophy and germinal center disruption in severe canine visceral leishmaniasis. PLoS ONE 2012; 7: e29103.
22. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, Konig P, et al. A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J Immunol 2010; 185: 6741-6752.
23. Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013; 38: 322-335.
24. Lewkowich IP, Lajoie S, Clark JR, Herman NS, Sproles AA, Wills-Karp M,. Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS ONE 2008; 3: e3879.
25. Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol 2014; 134: 440-450.
26. Peters M, Dudziak K, Stiehm M, Bufe A,. T-cell polarization depends on concentration of the danger signal used to activate dendritic cells. Immunol Cell Biol 2010; 88: 537-544.
27. Kobayashi T, Iijima K, Radhakrishnan S, Mehta V, Vassallo R, Lawrence CB, et al. Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol 2009; 182: 2502-2510.
28. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T,. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386: 181-185.
29. Kim YH, Yang TY, Park CS, Ahn SH, Son BK, Kim JH, et al. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 2012; 67: 183-190.
30. Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, et al. Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma 2012; 49: 738-743.
31. Kamijo S, Takeda H, Tokura T, Suzuki M, Inui K, Hara M, et al. IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J Immunol 2013; 190: 4489-4499.
32. Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012; 67: 1118-1126.
33. Licona-Limon P, Kim LK, Palm NW, Flavell RA,. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14: 536-542.
34. Klein Wolterink RG, Kleinjan A, van NM, Bergen I, de BM, Levani Y, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 2012; 42: 1106-1116.
35. Post S, Nawijn MC, Hackett TL, Baranowska M, Gras R, Van Oosterhout AJ, et al. The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation. Thorax 2012; 67: 488-495.